Drug Testing for Contractor Employees (Renewal)

ICR 201808-2030-001

OMB: 2030-0044

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2018-08-08
IC Document Collections
ICR Details
2030-0044 201808-2030-001
Active 201503-2030-002
EPA/OMS 2183.07
Drug Testing for Contractor Employees (Renewal)
Extension without change of a currently approved collection   No
Regular
Approved without change 09/25/2018
Retrieve Notice of Action (NOA) 08/15/2018
In accordance with 5 CFR 1320, the information collection is approved for three years. The Agency has clarified that it does not require drug testing of contractor employees, but rather that it requires the contractor to provide employees that have been drug tested. Should the agency begin to require drug testing, this ICR should be modified to reflect appropriate protections of respondent privacy.
  Inventory as of this Action Requested Previously Approved
09/30/2021 36 Months From Approved 09/30/2018
500 0 450
1,125 0 1,013
0 0 0

This ICR applies to a contractor who performs response services at sensitive sites with serious security concerns where the Agency and public interest would best be protected through drug testing of contractor employees. The contractor will test employees for the use of marijuana, cocaine, opiates, amphetamines, phencyclidine (PCP), and any other controlled substances. Only contractor employees who have been tested within the previous 90 calendar days and have passing drug test results may be directly engaged in on-site response work and/or on-site related activities at designated sites with significant security concerns. The Agency may request contractors responding to any of these types of incidents to conduct drug testing and apply Government-established suitability criteria in Title 5 CFR Administrative Personnel 731.104 Appointments Subject to Investigation, 732.201 Sensitivity Level Designations and Investigative Requirements, and 736.102 Notice to Investigative Sources when determining whether employees are acceptable to perform on given sites or on specific projects.

None
None

Not associated with rulemaking

  83 FR 22059 05/11/2018
83 FR 40274 08/14/2018
No

1
IC Title Form No. Form Name
Drug Testing for Contractor Employees (Renewal)

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 500 450 0 0 50 0
Annual Time Burden (Hours) 1,125 1,013 0 0 112 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
There is an increase of 112 hours in the total estimated respondent burden compared with the ICR currently approved by OMB. This increase is an adjustment due to more awarded contracts/orders performed on sensitive sites that require this drug testing for contractor employees.

$13,180
No
    No
    No
No
No
No
Uncollected
Thomas valentino 202 564-4522 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
08/15/2018


© 2024 OMB.report | Privacy Policy